A detailed history of High Tower Advisors, LLC transactions in Dexcom Inc stock. As of the latest transaction made, High Tower Advisors, LLC holds 68,663 shares of DXCM stock, worth $4.6 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares
68,663
Previous 92,168 25.5%
Holding current value
$4.6 Million
Previous $12.8 Million 39.1%
% of portfolio
0.01%
Previous 0.02%

Shares

29 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 13, 2024

SELL
$110.31 - $140.45 $2.59 Million - $3.3 Million
-23,505 Reduced 25.5%
68,663 $7.79 Million
Q1 2024

May 06, 2024

BUY
$114.22 - $140.1 $3.79 Million - $4.65 Million
33,176 Added 56.24%
92,168 $12.8 Million
Q4 2023

Feb 12, 2024

SELL
$75.49 - $124.16 $1.2 Million - $1.97 Million
-15,836 Reduced 21.16%
58,992 $7.32 Million
Q3 2023

Nov 08, 2023

BUY
$86.06 - $137.93 $927,726 - $1.49 Million
10,780 Added 16.83%
74,828 $6.98 Million
Q2 2023

Aug 14, 2023

BUY
$112.47 - $130.98 $477,210 - $555,748
4,243 Added 7.09%
64,048 $8.23 Million
Q1 2023

May 11, 2023

BUY
$104.0 - $122.92 $149,448 - $176,636
1,437 Added 2.46%
59,805 $6.95 Million
Q4 2022

Feb 08, 2023

SELL
$84.98 - $122.67 $522,796 - $754,665
-6,152 Reduced 9.54%
58,368 $6.61 Million
Q3 2022

Nov 09, 2022

SELL
$76.35 - $94.18 $463,749 - $572,049
-6,074 Reduced 8.6%
64,520 $5.2 Million
Q2 2022

Aug 10, 2022

BUY
$67.99 - $132.89 $3.4 Million - $6.65 Million
50,016 Added 243.06%
70,594 $5.26 Million
Q1 2022

May 12, 2022

SELL
$94.08 - $130.2 $256,932 - $355,576
-2,731 Reduced 11.72%
20,578 $10.6 Million
Q4 2021

Feb 10, 2022

BUY
$129.87 - $162.82 $720,778 - $903,651
5,550 Added 31.25%
23,309 $12.6 Million
Q3 2021

Nov 12, 2021

SELL
$106.71 - $143.18 $660,108 - $885,711
-6,186 Reduced 25.83%
17,759 $9.73 Million
Q2 2021

Aug 06, 2021

SELL
$80.99 - $107.93 $325,903 - $434,310
-4,024 Reduced 14.39%
23,945 $10.2 Million
Q1 2021

May 10, 2021

SELL
$84.79 - $104.74 $1.87 Million - $2.31 Million
-22,071 Reduced 44.11%
27,969 $10.1 Million
Q4 2020

Feb 10, 2021

BUY
$78.0 - $104.5 $1.65 Million - $2.21 Million
21,159 Added 73.26%
50,040 $18.5 Million
Q3 2020

Nov 13, 2020

SELL
$95.51 - $112.95 $1.2 Million - $1.42 Million
-12,561 Reduced 30.31%
28,881 $11.9 Million
Q2 2020

Aug 10, 2020

SELL
$62.68 - $105.34 $544,187 - $914,561
-8,682 Reduced 17.32%
41,442 $16.8 Million
Q1 2020

May 21, 2020

SELL
$47.79 - $75.63 $491,998 - $778,610
-10,295 Reduced 17.04%
50,124 $13.5 Million
Q4 2019

Feb 14, 2020

SELL
$36.62 - $57.29 $495,541 - $775,248
-13,532 Reduced 18.3%
60,419 $13.2 Million
Q3 2019

Nov 12, 2019

BUY
$35.53 - $43.8 $1.17 Million - $1.44 Million
32,901 Added 80.15%
73,951 $11 Million
Q2 2019

Aug 13, 2019

BUY
$27.84 - $38.92 $261,139 - $365,069
9,380 Added 29.62%
41,050 $6.15 Million
Q1 2019

May 15, 2019

SELL
$28.07 - $38.18 $804,991 - $1.09 Million
-28,678 Reduced 47.52%
31,670 $3.78 Million
Q4 2018

Feb 14, 2019

BUY
$26.99 - $37.37 $156,542 - $216,745
5,800 Added 10.63%
60,348 $7.24 Million
Q3 2018

Nov 09, 2018

SELL
$23.35 - $36.72 $330,612 - $519,918
-14,159 Reduced 20.61%
54,548 $7.84 Million
Q2 2018

Aug 14, 2018

SELL
$17.54 - $25.22 $1.06 Million - $1.52 Million
-60,174 Reduced 46.69%
68,707 $6.48 Million
Q1 2018

May 15, 2018

BUY
$13.06 - $18.54 $677,004 - $961,076
51,838 Added 67.28%
128,881 $9.53 Million
Q4 2017

Feb 14, 2018

SELL
$11.12 - $15.38 $121,285 - $167,749
-10,907 Reduced 12.4%
77,043 $4.4 Million
Q3 2017

Nov 14, 2017

BUY
$11.36 - $18.98 $540,077 - $902,347
47,542 Added 117.65%
87,950 $4.31 Million
Q2 2017

Aug 14, 2017

BUY
N/A
40,408
40,408 $2.96 Million

Others Institutions Holding DXCM

About DEXCOM INC


  • Ticker DXCM
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 386,257,984
  • Market Cap $25.9B
  • Description
  • DexCom, Inc., a medical device company, focuses on the design, development, and commercialization of continuous glucose monitoring (CGM) systems in the United States and internationally. The company provides its systems for use by people with diabetes, as well as for use by healthcare providers. Its products include DexCom G6, an integrated CGM ...
More about DXCM
Track This Portfolio

Track High Tower Advisors, LLC Portfolio

Follow High Tower Advisors, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of High Tower Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on High Tower Advisors, LLC with notifications on news.